BioCentury
ARTICLE | Company News

Sequitur sales and marketing update

June 2, 2003 7:00 AM UTC

Sequitur launched its Stealth RNAi technology for use in sequence-specific inhibition of gene expression. The company said its product avoids degradation by nucleases. ...